MASS - NASDAQ
908 Devices Inc.
$8.83
-0.23%908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
At a Glance
Live Snapshotmass
Total Current Liabilities
Last Annual Value
34.06M
3-Year CAGR
21%
5-Year CAGR
26%
10-Year CAGR
22%
908 Devices Inc. Competitors Analysis of Total Current Liabilities
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
908 Devices Inc. NASDAQ:MASS | 34.06M | 14.7% | 18.1% | N/A | |
 RxSight, Inc. NASDAQ:RXST | 26.25M | 7.9% | 18.8% | N/A | |
 Perspective Therapeutics, Inc. AMEX:CATX | 28.68M | 22.3% | 73.1% | 38.5% | |
 Aclaris Therapeutics, Inc. NASDAQ:ACRS | 28.64M | -2.5% | 4.6% | 16.5% | |
 Cerus Corporation NASDAQ:CERS | 100.80M | 14.3% | 5.1% | 14.1% | |
 CVRx, Inc. NASDAQ:CVRX | 13.32M | 19.2% | 17.7% | N/A | |
 Sight Sciences, Inc. NASDAQ:SGHT | 11.03M | -3.5% | -4.0% | N/A | |
 SANUWAVE Health, Inc. NASDAQ:SNWV | 17.85M | -34.9% | -20.5% | 8.5% | |
 Capricor Therapeutics, Inc. NASDAQ:CAPR | 35.84M | 4.6% | 54.0% | 22.0% | |
 Quanterix Corporation NASDAQ:QTRX | 74.76M | 24.2% | 15.1% | 21.2% | |
 Senseonics Holdings, Inc. NASDAQ:SENS | 24.35M | 12.2% | 5.8% | 7.7% |
908 Devices Inc. Fair Value Envelope
Related Guides
Continue your MASS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.